Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial
Primary Purpose
Gestational Diabetes, Hypoglycemia, Neonatal
Status
Unknown status
Phase
Phase 4
Locations
Finland
Study Type
Interventional
Intervention
Insulin, Aspart
Sponsored by
About this trial
This is an interventional treatment trial for Gestational Diabetes
Eligibility Criteria
Inclusion Criteria:
- pregnant women with gestational diabetes mellitus and daily insulin dosage of 30 IU or more
Exclusion Criteria:
- planned caesarean section,
- premature birth (< 37 gestational weeks)
Sites / Locations
- Obstetrics and Gynecology Unit: Tampere University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Insulin-glucose-infusion
Observation
Arm Description
Insulin-glucose-infusion is administered once active labour begins and will be continued until birth.
Plasma glucose level is measured every 1-2 hours during active labour and insulin-glucose-infusion is started if plasma glucose level exceeds 7,5 mmol/l in two subsequent measurements.
Outcomes
Primary Outcome Measures
Neonatal hypoglycemia
Neonatal plasma blood glucose < 3 mmol/l
Secondary Outcome Measures
Moderate neonatal hypoglycemia
Neonatal plasma blood glucose < 2,6 mmol/l
Severe neonatal hypoglycemia
Neonatal plasma blood glucose <2,2 mmol/l and/or demand of treatment
Duration of neonatal blood glucose monitoring
Proportion of participants needing insulin-glucose-infusion in the observational arm
Full Information
NCT ID
NCT02590016
First Posted
October 21, 2015
Last Updated
October 22, 2019
Sponsor
Tampere University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02590016
Brief Title
Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial
Official Title
Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: Insulin-Glucose-Infusion Versus Observational Approach - Is There a Difference in Neonatal Hypoglycemia Rate?
Study Type
Interventional
2. Study Status
Record Verification Date
October 2019
Overall Recruitment Status
Unknown status
Study Start Date
September 2015 (undefined)
Primary Completion Date
December 2020 (Anticipated)
Study Completion Date
November 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tampere University Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Pregnant women with gestational diabetes who are treated with insulin and their daily insulin dose is 30 IU or more will be randomized into two groups. Active treatment group will receive insulin-glucose-infusion during labour. In the observational group, blood glucose level during labour will be monitored and insulin-glucose-infusion is started only if needed. The hypothesis is that there will not be a difference in rate of hypoglycemia between the two groups and that the proportion of observational group participants that need infusion is low.
Detailed Description
Intrapartum blood glucose level has negative correlation to neonatal blood glucose level in type 1 diabetics. In gestational diabetes the correlation is less clear. In the view of current knowledge, it seems that moderately elevated intrapartum blood glucose may not cause neonatal hypoglycemia. There is no consensus of how to treat intrapartum blood glucose level in gestational diabetics. Some studies have implied that most of mothers with gestational diabetes would have normal blood glucose level during labour and hence would not need any intervention if their daily insulin dosage is less than 0,5-1 IU/kg.
Study participants are recruited into the study at Tampere University Hospital Maternity Ward when their daily insulin dose exceeds 30 IU. Randomization is done at 37th gestational week, if vaginal delivery is planned, and HbA1c is measured. Randomization envelope is opened at the delivery ward when active labour begins and treatment of blood glucose level is carried out accordingly. If insulin dose is 1 IU/kg or more, the participant is treated as in active treatment group despite of result of randomization. All neonates will receive milk substitute after birth in labour ward. Plasma glucose is measured immediately if neonate has symptoms of low blood sugar. If not, plasma glucose is measured approximately two hours after birth and after that every 4 hours until plasma glucose is 3,0 mmol/l or more in three consecutive measurements.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gestational Diabetes, Hypoglycemia, Neonatal
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Insulin-glucose-infusion
Arm Type
Experimental
Arm Description
Insulin-glucose-infusion is administered once active labour begins and will be continued until birth.
Arm Title
Observation
Arm Type
Active Comparator
Arm Description
Plasma glucose level is measured every 1-2 hours during active labour and insulin-glucose-infusion is started if plasma glucose level exceeds 7,5 mmol/l in two subsequent measurements.
Intervention Type
Drug
Intervention Name(s)
Insulin, Aspart
Other Intervention Name(s)
Novorapid
Intervention Description
Insulin aspart Novorapid® Penfill 40 IU/0,4 ml is diluted into 1000ml of 0,9 % sodium chloride (NaCl). Infusion is started at rate 48 ml/l, which equates insulin dosing at rate of 2 IU/h. Glucose infusion is started simultaneously. 5 ml of potassium chloride (KCl) is added to 500 ml of 10 % Glucose solution. Infusion rate is 100 ml/h giving glucose infusion rate of 10 g/l. Plasma glucose level is measured every 1-2 hours and infusion rate of insulin is increased by 6ml/h if plasma glucose is more than 7,5 mmol/l and decreased by 6 mmol/h if plasma glucose is below 4 mmol/l.
Primary Outcome Measure Information:
Title
Neonatal hypoglycemia
Description
Neonatal plasma blood glucose < 3 mmol/l
Time Frame
within 48 hours after birth
Secondary Outcome Measure Information:
Title
Moderate neonatal hypoglycemia
Description
Neonatal plasma blood glucose < 2,6 mmol/l
Time Frame
within 48 hours after birth
Title
Severe neonatal hypoglycemia
Description
Neonatal plasma blood glucose <2,2 mmol/l and/or demand of treatment
Time Frame
within 48 hours after birth
Title
Duration of neonatal blood glucose monitoring
Time Frame
within a week after birth
Title
Proportion of participants needing insulin-glucose-infusion in the observational arm
Time Frame
during active labour
10. Eligibility
Sex
Female
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
pregnant women with gestational diabetes mellitus and daily insulin dosage of 30 IU or more
Exclusion Criteria:
planned caesarean section,
premature birth (< 37 gestational weeks)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jukka Uotila, prof
Phone
+358331165244
Email
jukka.uotila@uta.fi
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elina Kivekäs, MD
Organizational Affiliation
Obstetrics and Gynecology Unit: Tampere University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Obstetrics and Gynecology Unit: Tampere University Hospital
City
Tampere
ZIP/Postal Code
33521
Country
Finland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elina Kivekäs, MD
Phone
+358331165244
Email
elina.kivekas@pshp.fi
12. IPD Sharing Statement
Citations:
PubMed Identifier
19432604
Citation
Barrett HL, Morris J, McElduff A. Watchful waiting: a management protocol for maternal glycaemia in the peripartum period. Aust N Z J Obstet Gynaecol. 2009 Apr;49(2):162-7. doi: 10.1111/j.1479-828X.2009.00969.x.
Results Reference
background
PubMed Identifier
22537519
Citation
Flores-le Roux JA, Sagarra E, Benaiges D, Hernandez-Rivas E, Chillaron JJ, Puig de Dou J, Mur A, Lopez-Vilchez MA, Pedro-Botet J. A prospective evaluation of neonatal hypoglycaemia in infants of women with gestational diabetes mellitus. Diabetes Res Clin Pract. 2012 Aug;97(2):217-22. doi: 10.1016/j.diabres.2012.03.011. Epub 2012 Apr 24.
Results Reference
background
PubMed Identifier
21163417
Citation
Garabedian C, Deruelle P. Delivery (timing, route, peripartum glycemic control) in women with gestational diabetes mellitus. Diabetes Metab. 2010 Dec;36(6 Pt 2):515-21. doi: 10.1016/j.diabet.2010.11.005.
Results Reference
background
PubMed Identifier
19225239
Citation
Maayan-Metzger A, Lubin D, Kuint J. Hypoglycemia rates in the first days of life among term infants born to diabetic mothers. Neonatology. 2009;96(2):80-5. doi: 10.1159/000203337. Epub 2009 Feb 19.
Results Reference
background
PubMed Identifier
21078733
Citation
Metzger BE, Persson B, Lowe LP, Dyer AR, Cruickshank JK, Deerochanawong C, Halliday HL, Hennis AJ, Liley H, Ng PC, Coustan DR, Hadden DR, Hod M, Oats JJ, Trimble ER; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics. 2010 Dec;126(6):e1545-52. doi: 10.1542/peds.2009-2257. Epub 2010 Nov 15.
Results Reference
background
PubMed Identifier
9475319
Citation
Stenninger E, Schollin J, Aman J. Early postnatal hypoglycaemia in newborn infants of diabetic mothers. Acta Paediatr. 1997 Dec;86(12):1374-6. doi: 10.1111/j.1651-2227.1997.tb14916.x.
Results Reference
background
PubMed Identifier
24292970
Citation
Ryan EA, Al-Agha R. Glucose control during labor and delivery. Curr Diab Rep. 2014 Jan;14(1):450. doi: 10.1007/s11892-013-0450-4.
Results Reference
background
PubMed Identifier
23231797
Citation
Ryan EA, Sia WW, Khurana R, Marnoch CA, Nerenberg KA, Ghosh M. Glucose control during labour in diabetic women. J Obstet Gynaecol Can. 2012 Dec;34(12):1149-1157. doi: 10.1016/S1701-2163(16)35462-7.
Results Reference
background
Learn more about this trial
Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial
We'll reach out to this number within 24 hrs